Wilson Quezada1, Eun Soo Kwak1, Joan Reibman2, Linda Rogers3, John Mastronarde4, William G Teague5, Christine Wei6, Janet T Holbrook6, Emily DiMango7. 1. Department of Medicine, Columbia University Medical Center, New York, New York. 2. New York University of Medicine, New York, New York. 3. Mount Sinai School of Medicine, New York, New York. 4. Ohio State University, Columbus, Ohio. 5. University of Virginia Medical Center, Charlottesville, Virginia. 6. Johns Hopkins University, Baltimore, Maryland. 7. Department of Medicine, Columbia University Medical Center, New York, New York. Electronic address: ead3@columbia.edu.
Abstract
BACKGROUND: Asthma exacerbations are associated with decreased quality of life and increased health care usage. Identification of characteristics that predict increased risk of future exacerbations in patients with suboptimal control of asthma could guide treatment decisions. OBJECTIVE: To examine patient characteristics associated with risk of asthma exacerbations in patients with uncontrolled persistent asthma. METHODS: A retrospective analysis of adults and children with inadequately controlled asthma despite asthma controller therapy and enrolled in 2 randomized trials was conducted. Baseline characteristics of subjects who experienced an asthma exacerbation during the treatment period were compared with those of subjects who did not experience an exacerbation. RESULTS: Of 718 subjects (402 adults and 295 children), 108 adults (27%) and 110 children (37%) experienced an asthma exacerbation during the study period. Unscheduled health care visits for asthma or use of oral corticosteroids in the previous year were significantly associated with asthma exacerbation during the study period (P < .01). Adult subjects who experienced an exacerbation had significantly lower forced expiratory volume in 1 second compared with those who did not (2.3 vs 2.5 L, respectively, P = .02). Children who experienced an exacerbation had lower baseline pre- and post-bronchodilator ratios of forced expiratory volume in 1 second to forced vital capacity (77% vs 81%, P < .01; 82% vs 86%, P < .001, respectively). Symptom scores on validated questionnaires were significantly worse in adults but not in children who developed an exacerbation. CONCLUSION: Spirometric measurements can help identify adults and children at increased risk for asthma exacerbation. Symptom scores could be helpful in identifying adults who are at high risk for exacerbations but could be less helpful in children.
RCT Entities:
BACKGROUND:Asthma exacerbations are associated with decreased quality of life and increased health care usage. Identification of characteristics that predict increased risk of future exacerbations in patients with suboptimal control of asthma could guide treatment decisions. OBJECTIVE: To examine patient characteristics associated with risk of asthma exacerbations in patients with uncontrolled persistent asthma. METHODS: A retrospective analysis of adults and children with inadequately controlled asthma despite asthma controller therapy and enrolled in 2 randomized trials was conducted. Baseline characteristics of subjects who experienced an asthma exacerbation during the treatment period were compared with those of subjects who did not experience an exacerbation. RESULTS: Of 718 subjects (402 adults and 295 children), 108 adults (27%) and 110 children (37%) experienced an asthma exacerbation during the study period. Unscheduled health care visits for asthma or use of oral corticosteroids in the previous year were significantly associated with asthma exacerbation during the study period (P < .01). Adult subjects who experienced an exacerbation had significantly lower forced expiratory volume in 1 second compared with those who did not (2.3 vs 2.5 L, respectively, P = .02). Children who experienced an exacerbation had lower baseline pre- and post-bronchodilator ratios of forced expiratory volume in 1 second to forced vital capacity (77% vs 81%, P < .01; 82% vs 86%, P < .001, respectively). Symptom scores on validated questionnaires were significantly worse in adults but not in children who developed an exacerbation. CONCLUSION: Spirometric measurements can help identify adults and children at increased risk for asthma exacerbation. Symptom scores could be helpful in identifying adults who are at high risk for exacerbations but could be less helpful in children.
Authors: Robert S Zeiger; Ashley Yegin; F Estelle R Simons; Tmirah Haselkorn; Lawrence Rasouliyan; Stanley J Szefler; Bradley E Chipps Journal: Ann Allergy Asthma Immunol Date: 2012-02 Impact factor: 6.347
Authors: Michael E Wechsler; Mario Castro; Erik Lehman; Vernon M Chinchilli; E Rand Sutherland; Loren Denlinger; Stephen C Lazarus; Stephen P Peters; Elliot Israel Journal: Am J Respir Crit Care Med Date: 2011-09-01 Impact factor: 21.405
Authors: Richard H Stanford; Alicia W Gilsenan; Ryan Ziemiecki; Xiaolei Zhou; William R Lincourt; Hector Ortega Journal: J Asthma Date: 2010-04 Impact factor: 2.515
Authors: Jasmina I Ivanova; Rachel Bergman; Howard G Birnbaum; Gene L Colice; Robert A Silverman; Kimmie McLaurin Journal: J Allergy Clin Immunol Date: 2012-02-11 Impact factor: 10.793
Authors: Eric D Bateman; Homer A Boushey; Jean Bousquet; William W Busse; Tim J H Clark; Romain A Pauwels; Søren E Pedersen Journal: Am J Respir Crit Care Med Date: 2004-07-15 Impact factor: 21.405
Authors: Stephen P Peters; Craig A Jones; Tmirah Haselkorn; David R Mink; David J Valacer; Scott T Weiss Journal: J Allergy Clin Immunol Date: 2007-05-03 Impact factor: 10.793
Authors: Tmirah Haselkorn; Robert S Zeiger; Bradley E Chipps; David R Mink; Stanley J Szefler; F Estelle R Simons; Marc Massanari; James E Fish Journal: J Allergy Clin Immunol Date: 2009-11 Impact factor: 10.793
Authors: Robert A Nathan; Christine A Sorkness; Mark Kosinski; Michael Schatz; James T Li; Philip Marcus; John J Murray; Trudy B Pendergraft Journal: J Allergy Clin Immunol Date: 2004-01 Impact factor: 10.793
Authors: Ronina A Covar; Stanley J Szefler; Robert S Zeiger; Christine A Sorkness; Mark Moss; David T Mauger; Susan J Boehmer; Robert C Strunk; Fernando D Martinez; Lynn M Taussig Journal: J Allergy Clin Immunol Date: 2008-10 Impact factor: 10.793
Authors: Audrey Buelo; Susannah McLean; Steven Julious; Javier Flores-Kim; Andy Bush; John Henderson; James Y Paton; Aziz Sheikh; Michael Shields; Hilary Pinnock Journal: Thorax Date: 2018-06-05 Impact factor: 9.139
Authors: David B Price; Sinthia Bosnic-Anticevich; Ian D Pavord; Nicolas Roche; David M G Halpin; Leif Bjermer; Omar S Usmani; Guy Brusselle; Simon Wan Yau Ming; Sarang Rastogi Journal: Clin Transl Allergy Date: 2019-08-21 Impact factor: 5.871